Trial NCT01980888

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-312-0123
Secondary IDs: 2013-003313-17

Last trial update was posted on 2018-11-19

MeSH Interventions

Bendamustine Hydrochloride Idelalisib Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukemia

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated in agreement with the FDA due to urgent safety measures. Due to early study termination, the prespecified efficacy analyses were not conducted. The PFS data presented are investigator assessments rather than IRC assessments.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID